2023 annual financial data

Syndax Pharmaceuticals 2023 Operating margin

Syndax Pharmaceuticals 2023 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -229,954,000 USD and net income was -209,360,000 USD.
Operating cash flow was -160,601,000 USD.

Get free Syndax Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-229,954,000 USD
Net income
-209,360,000 USD
Operating cash flow
-160,601,000 USD